>
the overall NIH consensus is that HCQ doesn’t help much with COVID-19That cited source does not support the stated proposition, nor is the study I linked "contrary" to that opinion.
The NIH says there is little to no benefit for hospitalized inpatient COVID-19 cases, i.e., those who have already developed severe illness before ever being given HCQ. The study I linked found evidence that it is significantly helpful in the early stages, preventing most hospitalizations from occurring in the first place. There is nothing inherently contradictory between those two propositions.
This seems not much different from, e.g., Theraflu. You wouldn't call that ineffective, would you?
